P. Bedford

发表

Vinca Alkaloids: Anti-vascular Effects in a Murine Tumour

Hosking Lk, P. Bedford, 1993 .

Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem® demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine

K. Hartmann, P. Bedford, S. Aspinall, 2012, Human vaccines & immunotherapeutics.

Phase 2 Clinical Trial of AttenuatedSalmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers

G. Dougan, M. Levine, C. Tacket, 2000, Infection and Immunity.

Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.

N. Bleehen, P. Workman, J. Ramsay, 1992, International journal of radiation oncology, biology, physics.

Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre‐exposed in vitro to either X‐irradiation or cisplatin

B. Hill, J. Masters, M. C. Walker, 1987, International journal of cancer.

An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines.

B. Hill, R. Whelan, P. Bedford, 1990, Biochemical pharmacology.

Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.

B. Hill, P. Bedford, A. Fichtinger-Schepman, 1990, International journal of radiation oncology, biology, physics.

Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II).

C. Mcauliffe, B. Hill, J. Masters, 1987, Chemico-biological interactions.

COMPARATIVE SAFETY AND IMMUNOGENICITY OF TWO YELLOW FEVER 17 D VACCINES ( ARILVAX AND YF-VAX ) IN A PHASE III MULTICENTER , DOUBLE-BLIND CLINICAL TRIAL

T. Monath, R. Shope, J. Tian, 2003 .

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

T. Monath, R. Shope, J. Tian, 2002, The American journal of tropical medicine and hygiene.

Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.

B. Hill, J. Masters, M. C. Walker, 1988, Cancer research.

Comparative Safety and Immunogenicity of Two Attenuated Enterotoxigenic Escherichia coli Vaccine Strains in Healthy Adults

D. Sack, E. Hall, A. L. Bourgeois, 2006, Infection and Immunity.

Exercise-Induced Serum Enzyme Elevations Confounding the Evaluation of Investigational Drug Toxicity: Report of Two Cases in a Vaccine Trial

T. Monath, Casey T Johnson, N. Kanesa-thasan, 2005, Human vaccines.

Repair of DNA interstrand crosslinks after busulphan

B. Fox, P. Bedford, 2004, Cancer Chemotherapy and Pharmacology.

Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru.

T. Monath, A. Magill, J. Olson, 2005, The American journal of tropical medicine and hygiene.

Automated determination of DNA using the fluorochrome Hoechst 33258.

G. Eisenbrand, P. Bedford, W. Sterzel, 1985, Analytical biochemistry.

DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas.

G. Eisenbrand, P. Bedford, 1984, Cancer research.

DNA-DNA interstrand crosslinking by dimethyanesulphonic acid esters. Correlation with cytotoxicity and antitumour activity in the Yoshida lymphosarcoma model and relationship to chain length.

B. Fox, P. Bedford, 1983, Biochemical pharmacology.

Dialkanesulphonates and Chromatin

B. Fox, P. Bedford, J. Hartley, 1984 .

The role of formaldehyde in methylene dimethanesulphonate-induced DNA cross-links and its relevance to cytotoxicity.

B. Fox, P. Bedford, 1981, Chemico-biological interactions.

A live, attenuated recombinant West Nile virus vaccine.

S. Green, F. Ennis, F. Guirakhoo, 2006, Proceedings of the National Academy of Sciences of the United States of America.

A comparative study of therapeutic activity, myelotoxicity and DNA damage in the bone marrow of mice after cyclophosphamide and ASTA Z 7557 (INN mafosfamide)

M. Kaufmann, W. Zeller, M. Berger, 2004, Investigational New Drugs.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

F. Guirakhoo, T. Monath, S. Yoksan, 2003, The Journal of infectious diseases.

Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.

B. Guy, T. Monath, Subhas Banerjee, 2002, Vaccine.

The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas

G. Eisenbrand, M. Berger, P. Bedford, 2004, Journal of Cancer Research and Clinical Oncology.

Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance.

B. Fox, P. Bedford, 1982, Cancer chemotherapy and pharmacology.

Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro.

B. Hill, R. Lock, R. Whelan, 1988, NCI monographs : a publication of the National Cancer Institute.

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.

F. Guirakhoo, T. Monath, S. Yoksan, 2002, Vaccine.

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers.

D. Sack, R. Sack, E. Hall, 2006, Vaccine.

Monitoring metabolic responses after induction of hypoxia in the KHT tumour using 31P NMR spectroscopy.

G. Adams, I. Stratford, C. Counsell, 1991, International journal of radiation biology.

Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

F. Guirakhoo, T. Monath, J. Lang, 2006, Human vaccines.

Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly

M. Cetron, T. Monath, L. Weld, 2005, Human vaccines.

A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.

P. Bedford, N. Bleehen, J. Roberts, 1995, British Journal of Cancer.